Decreased responsiveness of naturally occurring mutants of human estrogen receptor α to estrogens and antiestrogens

被引:8
作者
Komagata, Sayaka
Nakajima, Miki [1 ]
Tsuchiya, Yuki
Katoh, Miki
Kizu, Ryoichi
Kyo, Satoru
Yokoi, Tsuyoshi
机构
[1] Kanazawa Univ, Grad Sch Med Sci, Div Pharmaceut Sci, Kanazawa, Ishikawa 9201192, Japan
[2] Doshisha Womens Coll Liberal Arts, Fac Pharmaceut Sci, Kyoto 6100395, Japan
[3] Kanazawa Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Kanazawa, Ishikawa 9208641, Japan
关键词
estrogen receptor; mutation; transcriptional activity; estradiol; antiestrogens;
D O I
10.1016/j.jsbmb.2006.02.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Estrogen receptor a (ER alpha) is a ligand-inducible transcription factor that mediates the biological effects of estrogens and antiestrogens. Many point mutations in the human ER alpha gene have been reported to be associated with breast cancer, endometrial cancer, and psychiatric diseases. However, functional analyses for most mutants with amino acid changes are still lacking. In the present study, to investigate the effects of point mutations on the function, gel-shift assays and luciferase assays were performed for eight kinds of mutated ER alpha proteins, including a single nucleotide change of C207G (N69K), G478T (G160C), T887C (L296P), A908G (K303R), C926T (S309F), A1058T (E353V), A1186G (M396V), and G1231deletion (411fsX7). The mutated ER alpha expression plasmids were constructed by site-directed mutagenesis. With gel-shift assays using in vitro translated ER alpha proteins, binding to the consensus estrogen response element (ERE) was observed for the mutated ER alpha proteins except ER alpha (G160C) and ERa (411 fsX7), the binding of which was comparable with that of the wild type. Western blot analyses showed that ER alpha (G160C) could not be efficiently translated with the in vitro transcription/translation system and that ER alpha (411 fsX7) produced a truncated protein. To investigate the transactivation potency, wild-type or mutated ER alpha expression plasmids were co-transfected with pGL3-3EREc38 reporter plasmid into human breast adenocarcinoma MDA-MB-435 cells. The concentration-response curves (10 pM-100 nM E2) of the mutant ER alpha proteins except ER alpha (E353V) and ER alpha (411fsX7) were similar to that of wild-type ER alpha. However, at a low level of E2 (100pM), the mutants ER alpha (N69K), ER alpha (L296P), ER alpha (S309F), and ER alpha (M396V) showed a significant decrease of transactivation compared with that of the wild-type ER alpha. The mutants ER alpha (E353V) and ER alpha (411fsX7) did not show responsiveness to E2 and antiestrogens, 4-hydroxytamoxifen (40HT) and ICI 182,780. The mutant ER alpha (S309F) showed decreased responsiveness for the antiestrogenicity of 40HT. In conclusion, we found that some of the naturally occurring human ERa mutants with amino acid changes may have an altered responsiveness to estrogen and antiestrogens. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:79 / 86
页数:8
相关论文
共 38 条
[1]  
Andersen TI, 1997, HUM MUTAT, V9, P531
[2]   Aspartate 351 of estrogen receptor α is not crucial for the antagonist activity of antiestrogens [J].
Anghel, SI ;
Perly, V ;
Melançon, G ;
Barsalou, A ;
Chagnon, S ;
Rosenauer, A ;
Miller, WH ;
Mader, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (27) :20867-20872
[3]   THE ESTROGEN-RECEPTOR [J].
AUCHUS, RJ ;
FUQUA, SAW .
BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1994, 8 (02) :433-449
[4]   ROLE OF THE 2 ACTIVATING DOMAINS OF THE ESTROGEN-RECEPTOR IN THE CELL-TYPE AND PROMOTER-CONTEXT DEPENDENT AGONISTIC ACTIVITY OF THE ANTIESTROGEN 4-HYDROXYTAMOXIFEN [J].
BERRY, M ;
METZGER, D ;
CHAMBON, P .
EMBO JOURNAL, 1990, 9 (09) :2811-2818
[5]   Molecular basis of agonism and antagonism in the oestrogen receptor [J].
Brzozowski, AM ;
Pike, ACW ;
Dauter, Z ;
Hubbard, RE ;
Bonn, T ;
Engstrom, O ;
Ohman, L ;
Greene, GL ;
Gustafsson, JA ;
Carlquist, M .
NATURE, 1997, 389 (6652) :753-758
[6]   A NATURALLY-OCCURRING ESTROGEN-RECEPTOR MUTATION RESULTS IN INCREASED ESTROGENICITY OF A TAMOXIFEN ANALOG [J].
CATHERINO, WH ;
WOLF, DM ;
JORDAN, VC .
MOLECULAR ENDOCRINOLOGY, 1995, 9 (08) :1053-1063
[7]   THE USE OF ESTROGENS AND PROGESTINS AND THE RISK OF BREAST-CANCER IN POSTMENOPAUSAL WOMEN [J].
COLDITZ, GA ;
HANKINSON, SE ;
HUNTER, DJ ;
WILLETT, WC ;
MANSON, JE ;
STAMPFER, MJ ;
HENNEKENS, C ;
ROSNER, B ;
SPEIZER, FE .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (24) :1589-1593
[8]   Estrogen receptor null mice: What have we learned and where will they lead us? [J].
Couse, JF ;
Korach, KS .
ENDOCRINE REVIEWS, 1999, 20 (03) :358-417
[9]  
DESOMBRE ER, 1986, CANCER RES, V46, P4256
[10]   THE STEROID AND THYROID-HORMONE RECEPTOR SUPERFAMILY [J].
EVANS, RM .
SCIENCE, 1988, 240 (4854) :889-895